Kolltan Pharmaceuticals, Inc.

Kolltan Pharmaceuticals, Inc.

Kolltan Pharmaceuticals, Inc.

Overview
Date Founded

2007

Headquarters

300 GEORGE STREET SUITE 530 NEW HAVEN CT 06511

Type of Company

Private

Employees (Worldwide)

11 - 50

Industries

Pharmaceuticals
Retail: Drug Stores
Medical Support Services
Biotechnology

Company Description

Kolltan Pharmaceuticals, Inc. engages in the development of monoclonal antibody drugs. It focuses on the discovery and development of novel antibody-based drugs targeting receptor tyrosine kinases (RTKs) for the treatment of cancer and other diseases. The company was founded by Arthur G. Altschul, Jr. and Joseph P. Schlessinger in November 16, 2007 and is headquartered in New Haven, CT.

Contact Data
Trying to get in touch with decision makers at Kolltan Pharmaceuticals, Inc.? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Executives & Employees

General Counsel

Head of Scientific Research

Director

Director

Lab Manager

Senior Scientist

Scientist

Accountant

Investor Inquiries

Board of Directors

Co-Founder & Chief Executive Officer at Inozyme Pharma, Inc.

Co-Founder at Kolltan Pharmaceuticals, Inc.

Chief Executive Officer at Cognoptix, Inc.

Paths to Kolltan Pharmaceuticals, Inc.
Potential Connections via
Relationship Science
You
Kolltan Pharmaceuticals, Inc.
Recent Transactions
Details Hidden

Celldex Therapeutics Inc. purchases Kolltan Pharmaceuticals, Inc. from HBM Partners AG, Osage Partners LLC, Elm Street Venture Advisors, Inc., Auven Therapeutics Management LLLP, Tichenor Ventures LLC, Sectoral Asset Management Inc (Private Equity)

Details Hidden

Kolltan Pharmaceuticals, Inc. raised money in a private placement transaction

Details Hidden

Kolltan Pharmaceuticals, Inc. raised money in a private placement transaction

Transaction Advisors
Investment Advisor

Advised onCelldex Therapeutics Inc. purchases Kolltan Pharmaceuticals, Inc. from HBM Partners AG, Osage Partners LLC, Elm Street Venture Advisors, Inc., Auven Therapeutics Management LLLP, Tichenor Ventures LLC, Sectoral Asset Management Inc (Private Equity)

Legal Advisor

Advised onCelldex Therapeutics Inc. purchases Kolltan Pharmaceuticals, Inc. from HBM Partners AG, Osage Partners LLC, Elm Street Venture Advisors, Inc., Auven Therapeutics Management LLLP, Tichenor Ventures LLC, Sectoral Asset Management Inc (Private Equity)

Legal Advisor

Advised onCelldex Therapeutics Inc. purchases Kolltan Pharmaceuticals, Inc. from HBM Partners AG, Osage Partners LLC, Elm Street Venture Advisors, Inc., Auven Therapeutics Management LLLP, Tichenor Ventures LLC, Sectoral Asset Management Inc (Private Equity)

Advisors & Consultants
Consultant

Former Chief Medical Officer & Senior Vice President-Clinical Affairs at Kolltan Pharmaceuticals, Inc.

Investors
Details Hidden

ADC Products Switzerland SARL develops antibody drug for the treatment of cancer. The company is headquartered in Epalinges, Switzerland.

Details Hidden

HBM Healthcare Investments AG is an investment company, which invests in the healthcare sector. Its primary business activity is the acquisition, holding and sale of equity interests in companies in the human medicine sector. The company's focus of investment is on follow-on financing for existing portfolio companies. HBM Healthcare Investments was founded on July 12, 2001 and is headquartered in Zug, Switzerland.

Details Hidden

Purdue Pharma LP engages in the development and provision of prescription medicines. It offers a portfolio of medical products in various categories, including prescription opioids, sleep, laxatives, antiseptics, and dietary supplement. The company was founded by Raymond R. Sackler in 1991 and is headquartered in Stamford, CT.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Kolltan Pharmaceuticals, Inc.. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Kolltan Pharmaceuticals, Inc.'s profile does not indicate a business or promotional relationship of any kind between RelSci and Kolltan Pharmaceuticals, Inc..